ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Roma, Lazio, ITA:

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

effective for treating people who have excess body weight and type 2 diabetes. There are 2 study treatments in this study taken as injection...

Enrolling
Diabetes Mellitus
Overweight
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

Phase 3

Novo Nordisk
Novo Nordisk

Rome, Lazio, Italy and 72 other locations

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM an...

Enrolling
Type 2 Diabetes Mellitus
Drug: Elecoglipron
Drug: Semaglutide

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 208 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or ov...

Active, not recruiting
Type 1 Diabetes
Overweight
Drug: Tirzepatide
Drug: Placebo

Phase 3

Lilly
Lilly

Roma, Italy and 145 other locations

This study compares insulin icodec, taken once a week, with other basal insulins, taken once a day, in people with type 2 diabetes.The purpo...

Enrolling
Diabetes Mellitus, Type 2
Drug: Basal insulin analogues
Drug: Insulin icodec

Phase 4

Novo Nordisk
Novo Nordisk

Roma, Italy and 75 other locations

with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes...

Enrolling
Type 1 Diabetes Mellitus
Drug: Teplizumab
Other: Placebo

Phase 3

Sanofi
Sanofi

Rome, Roma, Italy and 204 other locations

This study is being conducted to find out how well zenagamtide works and how safe it is compared to insulin glargine in participants with type 2 diabetes...

Enrolling
Type 2 Diabetes
Cardiovascular Risk
Drug: Zenagamtide
Drug: Insulin glargine U-100

Phase 3

Novo Nordisk
Novo Nordisk

Roma, RM, Italy and 330 other locations

receptor agonist (RA), at multiple doses compared with placebo for weight management in participants with obesity or overweight and Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Obesity or Overweight
Combination Product: Enicepatide
Combination Product: Placebo

Phase 3

Roche
Roche

Rome, Lazio, Italy and 209 other locations

Recently updated

of this study is to evaluate the efficacy and safety of eloralintide compared with a placebo in participants with obesity or overweight, type 2 diabetes...

Begins enrollment this month
Diabetes Mellitus, Type 2
Overweight
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Roma, Italy and 307 other locations

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Roma, Italy and 90 other locations

in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME)In the first year, all 3 treatment groups w...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: Remigromig
Drug: Ranibizumab

Phase 2, Phase 3

EyeBiotech

Rome, Italy and 180 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems